Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI).
Saved in:
| Title: | Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI). |
|---|---|
| Authors: | Carberry J; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Golden Jubilee National Hospital, Clydebank, UK., Petrie MC; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Lee MMY; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Stanley B; Robertson Centre for Biostatistics, School of Health and Wellbeing, University of Glasgow, Glasgow, UK., Brooksbank KJM; West of Scotland Innovation Hub, National Health Service Scotland, Glasgow, UK., Campbell RT; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Golden Jubilee National Hospital, Clydebank, UK., Good R; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Golden Jubilee National Hospital, Clydebank, UK., Jhund PS; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Kellman P; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Lang NN; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Lindsay MM; Golden Jubilee National Hospital, Clydebank, UK., Mangion K; Golden Jubilee National Hospital, Clydebank, UK., Gardner RS; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Golden Jubilee National Hospital, Clydebank, UK., Mark PB; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Meyer B; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., O'Donnell J; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Orchard V; Golden Jubilee National Hospital, Clydebank, UK., Shaukat A; Golden Jubilee National Hospital, Clydebank, UK., Watkins S; Golden Jubilee National Hospital, Clydebank, UK., McConnachie A; Robertson Centre for Biostatistics, School of Health and Wellbeing, University of Glasgow, Glasgow, UK., McMurray JJV; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Welsh P; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Sattar N; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Berry C; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Golden Jubilee National Hospital, Clydebank, UK., Docherty KF; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK. |
| Source: | European journal of heart failure [Eur J Heart Fail] 2025 Mar; Vol. 27 (3), pp. 566-576. Date of Electronic Publication: 2024 Dec 15. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1879-0844 |
|---|---|
| DOI: | 10.1002/ejhf.3560 |
